Manesh Dixit - Sunrise FL, US Chih-Ming Chen - Taipei, TW Xiu Xiu Cheng - Weston FL, US Jianbo Xie - Davie FL, US
Assignee:
Andrx Pharmaceuticals, Inc. - Davie FL
International Classification:
A61K 9/48 A61K 9/26
US Classification:
424452, 424463
Abstract:
A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.
Manesh Dixit - Sunrise FL, US Chih-Ming Chen - Taipei, TW Jianbo Xie - Davie FL, US
Assignee:
Andrx Pharmaceuticals, Inc. - Davie FL
International Classification:
A61K 9/48 A61K 9/26
US Classification:
424452, 424463
Abstract:
A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.
Xiu Cheng - Weston FL, US Xiaohong Qi - Dave FL, US Guohua Zhang - Parsippany NJ, US Manesh Dixit - Sunrise FL, US
International Classification:
A61K 9/26 A61K 31/554
US Classification:
424469000, 514211070
Abstract:
A controlled release diltiazem dosage formulation comprising a plurality of diltiazem pellets and a gel-forming material where the time of maximum diltiazem blood plasma levels occurs more than 8 hours after administration and preferably more than 10 hours after administration.
Manesh Dixit - Sunrise FL, US Chih-Ming Chen - Taipei, TW Xiu Xiu Cheng - Davie FL, US Jianbo Xie - Davie FL, US
Assignee:
ANDRX PHARMACEUTICALS, INC. - Davie FL
International Classification:
A61K 9/30 A61K 9/36 A61K 31/4458
US Classification:
424465, 514317
Abstract:
A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.